Interleukin-10 Gene Polymorphism in Parkinson's Disease Patients

Archives of Medical Research

Volumn 38, Issue 8, 2007, Pages 858-863

  Bialecka, Monika ^a   Klodowska Duda, Gabriela ^b   Kurzawski, Mateusz ^a   Slawek, Jarosław ^c   Opala, Grzegorz ^b   Bialecki, Piotr ^a   Safranow, Krzysztof ^a   Droździk, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c ST ADALBERT HOSPITAL   (Poland)

Author keywords

Genetic polymorphism; Interleukin 10; Parkinson's disease

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; PARKINSON DISEASE; POLAND; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 34848892191     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.06.006     Document Type: Article

References (36)

1. Tan E.K., Khajavi M., Thornby J.I., Nagamitsu S., Jankovic J., and Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 55 (2000) 533-538
2. Samii A., Nutt J.G., and Ransom B.R. Parkinson's disease. Lancet 363 (2004) 1783-1793
3. Nagatsu T., Mogi M., Ichinose H., and Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm 60 Suppl (2000) 277-290
4. Nagatsu T., and Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 11 (2005) 999-1016
5. Wullner U., and Klockgether T. Inflammation in Parkinson's disease. J Neurol 250 Suppl 1 (2003) I35-I38
6. McGeer P.L., and McGeer E.G. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035 (2004) 104-116
7. Kruger R, Hardt C, Tschentscher F, Jackel S, Kuhn W, Muller T, et al. Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm 200;107:553-562.
8. Nishimura M., Mizuta I., Mizuta E., Yamasaki S., Ohta M., and Kuno S. Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci Lett 284 (2000) 73-76
9. Nishimura M., Mizuta I., Mizuta E., Yamasaki S., Ohta M., Kaji R., et al. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease. Neurosci Lett 311 (2001) 1-4
10. Kaltschmidt B., Baeuerle P.A., and Kaltschmidt C. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol Aspects Med 14 (1993) 171-190
11. Lee Y.B., Nagai A., and Kim S.U. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69 (2002) 94-103
12. Bessler H., Djaldetti R., Salman H., Bergman M., and Djaldetti M. IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother 53 (1999) 141-145
13. Lio D., Licastro F., Scola L., Chiappelli M., Grimaldi L.M., Crivello A., et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 4 (2003) 234-238
14. Huerta C., Alvarez V., Mata I.F., Coto E., Ribacoba R., Martinez C., et al. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease. Neurosci Lett 370 (2004) 151-154
15. 's disease. Neurosc Lett 326 (2002) 70-72
16. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., and Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95 (1998) 9465-9470
17. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., Bansal A., Shorthouse C., and Powell E.E. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (1999) 526-530
18. Lim S., Crawley E., Woo P., and Barnes P.J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352 (1998) 113
19. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., and Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166 (2001) 3915-3922
20. Kaluza W., Leirisalo-Repo M., Marker-Hermann E., Westman P., Reuss E., Hug R., et al. IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 44 (2001) 1209-1214
21. Keen L.J., DeFor T.E., Bidwell J.L., Davies S.M., Bradley B.A., and Hows J.M. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 103 (2004) 3599-3602
22. Daniel S.E., and Lees A.J. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm 39 Suppl (1993) 165-172
23. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 17 (1967) 427-442
24. West A.B., Maraganore D., Crook J., Lesnick T., Lockhart P.J., Wilkes K.M., et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 11 (2002) 2787-2792
25. Gustincich S., Manfioletti G., Del Sal G., Schneider C., and Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11 (1991) 298-300 302
26. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
27. Kurzawski M., Pawlik A., Czerny B., Domanski L., Rozanski J., and Drozdzik M. Frequencies of the common promoter polymorphisms in cytokine genes in a Polish population. Int J Immunogenet 32 (2005) 285-291
28. Dodel R.C., Lohmuller F., Du Y., Eastwood B., Gocke P., Oertel W.H., et al. A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease. Neurology 56 (2001) 982-983
29. Williams K., Dooley N., Ulvestad E., Becher B., and Antel J.P. IL-10 production by adult human derived microglial cells. Neurochem Int 29 (1996) 55-64
30. Gallagher P.M., Lowe G., Fitzgerald T., Bella A., Greene C.M., McElvaney N.G., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58 (2003) 154-156
31. Pickard C., Mann C., Sinnott P., Boggild M., Hawkins C., Strange R.C., et al. Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis. J Neuroimmunol 101 (1999) 207-210
32. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafe M., et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40 (2003) 296-299
33. Poli F., Nocco A., Berra S., Scalamogna M., Taioli E., Longhi E., et al. Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 29 (2002) 237-240
34. Koss K., Fanning G.C., Welsh K.I., and Jewell D.P. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun 1 (2000) 321-324
35. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafe M., et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3 (2002) 30-33
36. Bonafe M., Olivieri F., Cavallone L., Giovagnetti S., Mayegiani F., Cardelli M., et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31 (2001) 2357-2361